INCASSIA Drug Patent Profile
✉ Email this page to a colleague
When do Incassia patents expire, and what generic alternatives are available?
Incassia is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in INCASSIA is norethindrone. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Incassia
A generic version of INCASSIA was approved as norethindrone by GLENMARK PHARMS LTD on July 22nd, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INCASSIA?
- What are the global sales for INCASSIA?
- What is Average Wholesale Price for INCASSIA?
Summary for INCASSIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Patent Applications: | 3,802 |
| Drug Prices: | Drug price information for INCASSIA |
| DailyMed Link: | INCASSIA at DailyMed |
Pharmacology for INCASSIA
| Drug Class | Progestin |
US Patents and Regulatory Information for INCASSIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | INCASSIA | norethindrone | TABLET;ORAL-28 | 207304-001 | Sep 23, 2016 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
